DK1328814T3 - Fremgangsmåde til identifikation in vivo af intracellulære epitoper - Google Patents

Fremgangsmåde til identifikation in vivo af intracellulære epitoper

Info

Publication number
DK1328814T3
DK1328814T3 DK01983776T DK01983776T DK1328814T3 DK 1328814 T3 DK1328814 T3 DK 1328814T3 DK 01983776 T DK01983776 T DK 01983776T DK 01983776 T DK01983776 T DK 01983776T DK 1328814 T3 DK1328814 T3 DK 1328814T3
Authority
DK
Denmark
Prior art keywords
peptide
recognise
molecule
cells
vivo identification
Prior art date
Application number
DK01983776T
Other languages
English (en)
Inventor
Antonino Cattaneo
Michela Visintin
Original Assignee
S I S S A Scuola Internaz Supe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S I S S A Scuola Internaz Supe filed Critical S I S S A Scuola Internaz Supe
Application granted granted Critical
Publication of DK1328814T3 publication Critical patent/DK1328814T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK01983776T 2000-10-24 2001-10-22 Fremgangsmåde til identifikation in vivo af intracellulære epitoper DK1328814T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000561A IT1317922B1 (it) 2000-10-24 2000-10-24 Metodo per identificare in vivo epitopi intracellulari.
PCT/IT2001/000535 WO2002035237A2 (en) 2000-10-24 2001-10-22 Method for in vivo identification of intracellular epitopes

Publications (1)

Publication Number Publication Date
DK1328814T3 true DK1328814T3 (da) 2007-01-29

Family

ID=11454967

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01983776T DK1328814T3 (da) 2000-10-24 2001-10-22 Fremgangsmåde til identifikation in vivo af intracellulære epitoper

Country Status (12)

Country Link
US (1) US20030235850A1 (da)
EP (1) EP1328814B1 (da)
JP (1) JP2004512529A (da)
AT (1) ATE342511T1 (da)
AU (1) AU2002215194A1 (da)
CA (1) CA2426744A1 (da)
DE (1) DE60123819T2 (da)
DK (1) DK1328814T3 (da)
ES (1) ES2272553T3 (da)
IT (1) IT1317922B1 (da)
PT (1) PT1328814E (da)
WO (1) WO2002035237A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799535B1 (en) 1997-12-09 2010-09-21 Arch Development Corporation Methods for identifying factors that control the folding of amyloid proteins of diverse origin
CA2438661C (en) 2001-02-15 2011-05-31 University Of Chicago Yeast screens for agents affecting protein folding
EP2709728B1 (en) * 2011-05-20 2019-01-23 Oligomerix, Inc. Tau protease methods of use
WO2013063613A2 (en) * 2011-10-28 2013-05-02 University Of Maryland Methods and compositions related to intracellular neutralization by igg
HUE052232T2 (hu) 2013-05-06 2021-04-28 Scholar Rock Inc Készítmények és eljárások növekedési faktor modulálására
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
US20170306046A1 (en) 2014-11-12 2017-10-26 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
ITUB20155272A1 (it) 2015-11-02 2017-05-02 Scuola Normale Superiore Intracellular antibody
CN108463248B (zh) 2015-11-12 2022-10-21 西雅图基因公司 聚糖相互作用化合物及使用方法
EP3541847A4 (en) 2016-11-17 2020-07-08 Seattle Genetics, Inc. COMPOUNDS INTERACTING WITH GLYCANE AND METHODS OF USE
EP3589319A4 (en) 2017-03-03 2021-07-14 Seagen Inc. GLYCAN INTERACTING COMPOUNDS AND METHOD OF USE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2344886B (en) * 1999-03-10 2000-11-01 Medical Res Council Selection of intracellular immunoglobulins
ATE273323T1 (de) * 1999-12-28 2004-08-15 Esbatech Ag INTRAKÖRPER MIT DEFINIERTER STRUKTUR (ßFRAMEWORKß), DIE IN EINER REDUZIERENDEN UMGEBUNG STABIL IST, UND IHRE VERWENDUNGEN

Also Published As

Publication number Publication date
PT1328814E (pt) 2007-01-31
IT1317922B1 (it) 2003-07-15
WO2002035237A3 (en) 2002-10-10
DE60123819T2 (de) 2007-08-02
US20030235850A1 (en) 2003-12-25
AU2002215194A1 (en) 2002-05-06
JP2004512529A (ja) 2004-04-22
ATE342511T1 (de) 2006-11-15
EP1328814B1 (en) 2006-10-11
EP1328814A2 (en) 2003-07-23
ES2272553T3 (es) 2007-05-01
WO2002035237A2 (en) 2002-05-02
DE60123819D1 (de) 2006-11-23
ITRM20000561A0 (it) 2000-10-24
ITRM20000561A1 (it) 2002-04-24
CA2426744A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
WO2002020569A3 (en) Mammalian genes; related reagents and methods
GB2383331A (en) Monoclonal antibody DS6 Tumor-associated antigen CA6 and methods of use thereof
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
IT1317922B1 (it) Metodo per identificare in vivo epitopi intracellulari.
AU3117201A (en) Methods and compositions for generating human monoclonal antibodies
DE60109443D1 (de) Antigene zusammensetzung die ein polykationisches peptid und inosin und cytosin enthält
HRP20030087B1 (en) Anti-il-12 antibodies, compositions, methods and uses
RU94045919A (ru) Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция
CY1114047T1 (el) Νεοι φορεις εκφρασης και χρησεις αυτων
WO1998022510A3 (en) Methods for the production of chicken monoclonal antibodies
IL273648B1 (en) Microbiota sequence variants of tumor-related antigenic epitopes
Jeppesen et al. Multiple Plasmodium falciparum erythrocyte membrane protein 1 variants per genome can bind IgM via its Fc fragment Fcμ
DE602006019598D1 (de) Neuartige phagenanzeigetechnologien
PT1119630E (pt) Construcoes de acido nucleico para imunizacao genetica
NZ547629A (en) Antibodies binding to conformationally discriminating epitopes of human IGG Fc receptor IIb and IIb
RU94046414A (ru) Моноклональные антитела к гликопротеину р, их получение и применение, продуцирующие их клетки, иммунологический диагностический набор на их основе, терапевтический состав
WO1999058678A3 (en) Antibodies to dendritic cells and human dendritic cell populations and uses thereof
EA200600738A1 (ru) Способ
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
ATE337336T1 (de) Nukleinsäuren, die für stichodactylidae chromoproteine kodieren
AP2368A (en) Novel expression vectors and uses thereof.
ATE410693T1 (de) Hcv-test
DE69533504D1 (de) Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
WO2005020891A3 (en) Monoclonal antibodies against ricin toxin and methods of making and using thereof